Introduction
============

Pneumonia is one of the leading causes of morbidity and mortality in under-5 children causing about 1.6 million deaths every year globally.[@b1] According to a recent report published in 2010, 18% of the total 8.8 million global deaths among under-5 children in 2008 were due to pneumonia.[@b1] There is an estimated incidence of 151 million new cases of childhood pneumonia each year globally, including 61 million cases in southeast Asia, and 11--20 million (7%--13%) are severe enough to require hospitalisation in developing countries.[@b2] An estimated 1.9 million children died from acute respiratory infection globally in 2000 and 70% of these deaths occurred in Africa and Southeast Asia.[@b5] [@b6] In Bangladesh, acute lower respiratory infection accounts for 25% of \<5-year-old child deaths and 40% of infantile deaths.[@b7] Recent reports have shown that pneumonia accounts for about 14% and 12% deaths from community-based[@b1] and hospital-based studies[@b8] of \<5-year-old child in Bangladesh, respectively. Although community case management of non-severe pneumonia[@b9] as well as severe pneumonia by lady health worker with oral antibiotics[@b10] and ambulatory home treatment with high-dose oral amoxicillin[@b11] has been reported from Pakistan, the WHO\'s guidelines for case management of pneumonia still recommend that children with severe pneumonia require facility-based management with parenteral antibiotics[@b12] but an inadequate number of paediatric beds limits hospital care in Bangladesh. This inadequate capacity assuredly results in excess and unnecessary death of children, who, with proper care, would otherwise survive. We, therefore, developed the concept of a 'day care' model[@b13] through establishment of facilities at 'outpatient clinics' for management of common childhood illnesses, such as severe acute malnutrition[@b13] and severe pneumonia,[@b14] [@b15] hoping to provide greater curative or case management benefits to Bangladeshi children and thus reducing morbidity and deaths, the results of which demonstrated that it is possible to successfully manage childhood pneumonia with antibiotics, feeding and supportive care for a week.[@b14] [@b15] However, there is little information about what happens after recovery from pneumonia and whether this recovery is sustained in their homes over a longer period. Short-term successes, if not sustained, and/or if associated with higher rates of relapse or recurrence or death would not be acceptable as a public health intervention. The reasons for death, or relapse or other morbidities need to be understood, and deaths are likely when medical care and treatment are inaccessible. Therefore, we described the novelty of the current observational study by comparing 3 months outcomes post-discharge and also by providing some limited data on the morbidity and mortality for severe pneumonia post-discharge.

Objectives
==========

The objectives of the study were (1) to describe the features of relapse, morbidity, mortality and re-hospitalisation following successful discharge after severe pneumonia in \<5-year-old children in urban Dhaka, Bangladesh; (2) to compare the compliance, relapse, morbidity, mortality and re-hospitalisation rates between an outpatient-managed day care group and a hospital-managed group over 3 months and (3) to explore the predictors of treatment failures for 3 months of follow-up.

Study design
------------

An observational study following two cohorts of children with severe pneumonia who were discharged either from the outpatient day care clinic or from the hospital after recovery from their primary illness during the long-term post-management follow-up of children enrolled in another randomised controlled trial.[@b15]

Settings
--------

The day care was provided at the Radda Clinic and the hospital care was provided at the Institute of Child Health and Shishu Sasthya Foundation Hospital (ICHSH), both located at Mirpur, Dhaka, Bangladesh. For the follow-up study, the Radda Clinic remained open from 08:00 to 17:00 h on each day including the weekends and holidays, but the hospital remained open for 24 h. Mothers usually came for follow-up visits during the morning hours between 09:00 and 12:00, but only few came in the afternoon. All the project staff including study physicians, nurses and healthcare workers remained available at the clinic and hospital during the above opening hours for conducting other ongoing projects during that period, and they were also routinely performing the follow-up visits.

Participants
------------

In the above-mentioned original reference study,[@b15] we compared the outpatient day care management with inpatient hospitalised management of children of either sex, aged 2--59 months, with severe pneumonia according to the WHO criteria.[@b12] From September 2006 through November 2008, they were randomised to receive day care management at a clinic or hospitalised management and then followed up for 3 months after discharge. The original study[@b15] including the follow-up was approved by the Research and Ethical Review Committees of the International Centre for Diarrhoeal Disease Research, Bangladesh. A written informed consent including the 3-month follow-up after discharge was obtained from the parents of each child before enrolment into the study.

Follow-up study
---------------

After successful day care/hospital care management at the Radda Clinic/ICHSH with antibiotics, food and supportive care, children were discharged,[@b15] while the study physicians mentioned all the dates for scheduled follow-up visits for the next 3 months in the discharge certificate and parents were advised to visit the respective clinic or hospital for follow-up assessment every 2 weeks for 3 months. At each follow-up visit, the study physician enquired the attending mothers/care givers about the signs and symptoms of specific morbidities since the previous visit. Morbidity data like respiratory (eg, cough, fever, running nose, difficulty in breathing, chest indrawing, rales on auscultation), diarrhoeal or others (eg, eye, ear, nose and skin infection, thrush, passage of worms) were recorded on a case report form. The vital signs (pulse, respiration, temperature, body weight, length/height and oxygen saturation) were recorded at each follow-up visit. The Z-scores for weight-for-age and weight-for-height were calculated during each follow-up visit to assess changes in nutritional status. We also recorded events such as relapses, deaths, unscheduled extra-visits and re-hospitalisations. Any child developing pneumonia, diarrhoea or other complications requiring re-hospitalisation during the follow-up period was referred to the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh/ICHSH for appropriate management. We also recorded the events related to hospitalisation of each child during the 3-month follow-up period. Other minor illnesses were treated by the study physician. Children who failed to attend the clinic/hospital on scheduled follow-up dates were visited in their homes by a healthcare worker next morning, who encouraged the parents to comply with follow-up visits and accompanied them back to the clinic/hospital on the same day for recording of all the above information by the study physician.

Data analysis including primary outcome measures
------------------------------------------------

Success of day care/hospital care management at follow-up visits is defined as compliance with each of the scheduled follow-up visits for 3 months either spontaneously or brought by the healthcare workers, without the need for re-hospitalisation, or development of hypoxaemia and not dying during the whole follow-up period. However, the failure of day care/hospital care management at follow-up visits actually means re-hospitalisation, or development of hypoxaemia or death at any time during the 3 months of follow-up period. All data were collected on pre-designed case report forms, edited, entered onto a personal computer and analysed using statistical software, for example, Statistical Package for Social Sciences (SPSS V.11.5; SPSS Inc), EPI Info V.6.0 and CIA. The primary outcome measures were expressed as the proportion of successes and failures of day care management at follow-up visits as determined by estimating ORs with their 95% CIs in comparison with hospital care results. The study groups were compared at the time of discharge from the clinic/hospital and during the follow-up period. The continuous variables were compared between the groups using Student t test and non-parametric tests. Dichotomous variables were compared using the χ^2^ test or Fisher\' exact test, as appropriate. A probability of \<0.05 was considered statistically significant.

Results
=======

In total, 360 children living in the Mirpur, Dhaka, Bangladesh, with severe pneumonia were enrolled into the original randomised controlled trial study[@b15] and were equally (180 in each) assigned randomly to the outpatient day care or inpatient hospital care ([figure 1](#fig1){ref-type="fig"}). The children were then followed up for 3 months after discharge from their primary treatment sites. The health status of the study children at the time of discharge from the clinic/hospital is shown in [table 1](#tbl1){ref-type="table"}. The mean age (SD) of the children was 8 (7) months, 291 (81%) were infants (2--11 months), 220 (61%) were men and 330 (92%) were breast fed with significantly more infants receiving the hospital care ([table 1](#tbl1){ref-type="table"}). Most of the children were well nourished without any wasting, but only with a mild degree of under-nutrition ([table 1](#tbl1){ref-type="table"}). About half of the children belonged to poor families (48%) with a monthly income of about US\$70, while 72% of the fathers were day labourers or rickshaw-pullers, and 87% of the mothers were housewives.
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###### 

Comparison of the 'health' status of the study children at the time of discharge

  Characteristics                                               Total (n=360)   Day care (n=180)   Hospital care (n=180)   p Value
  ------------------------------------------------------------- --------------- ------------------ ----------------------- ---------
  Male, n (%)                                                   220 (61)        102 (57)           118 (66)                0.08
  Age in month, mean (SD)                                       8 (7)           8.7 (8.0)          7.3 (6.8)               0.07
  Infants (2--11 months), n (%)                                 291 (81)        137 (76)           154 (86)                0.02
  12--59 months, n (%)                                          69 (19)         43 (24)            26 (14)                 0.02
  Breast fed, n (%)                                             330 (92)        163 (91)           167 (93)                0.44
  Weight on discharge, kg, mean (SD)                            6.59 (1.61)     6.67 (1.67)        6.52 (1.55)             0.40
  Height on discharge, cm, mean (SD)                            64.97 (7.69)    65.49 (8.28)       64.45 (7.03)            0.20
  Weight-for-age Z-score on discharge, mean (SD)                −1.47 (1.21)    −1.53 (1.21)       −1.41 (1.21)            0.36
  Weight-for-height Z-score on discharge, mean (SD)             −0.82 (1.10)    −0.83 (1.09)       −0.82 (1.12)            0.92
  Temperature, mean (SD)                                        37.8 (0.8)      37.7 (0.7)         37.8 (0.7)              0.08
  Pulse rate, beats per minute, mean (SD)                       130 (14)        130 (15)           130 (14)                0.71
  Respiratory rate, breaths per minute, mean (SD)               41 (9)          42 (10)            39 (8)                  0.007
  Difficulty in breathing, n (%)                                0               0                  0                       NA
  Lower chest wall indrawing, n (%)                             0               0                  0                       NA
  Hypoxaemia on discharge (oxygen saturation of \<95%), n (%)   0               0                  0                       NA
  Oxygen saturation (%) on discharge, mean (SD)                 98 (1)          98 (1)             98 (1)                  NA
  Length of clinic/hospital stay (days), mean (SD)              6.85 (2.61)     7.13 (2.36)        6.57 (2.81)             0.04
  Median length of stay (days)                                  6.00            6.00               6.00                    NA

Compliance with follow-up visits after discharge from the clinic/hospital gradually reduced over time following discharge: 95%, 93%, 89%, 88%, 86% and 85% for the first, second, third, fourth, fifth and sixth visits, respectively ([table 2](#tbl2){ref-type="table"}). The common symptoms and signs noted during the follow-up visits included cough (28%), fever (17%), diarrhoea (9%) and rapid breathing (7%), while less common symptoms were chest indrawing (5%), feeding difficulties (5%) and difficulty in breathing (3%) ([table 2](#tbl2){ref-type="table"}). About 14% of the children reported minor illnesses such as poor appetite, otitis media, conjunctivitis, oral candidiasis (thrush), scabies and other skin infections, but 19% of the children required medication during the follow-up period ([table 2](#tbl2){ref-type="table"}). The sustainability of 3-month follow-up in the study group after discharge from the day care clinic is similar (≈90%) to that of the control group after discharge from the hospital ([table 3](#tbl3){ref-type="table"}). A significantly higher number of hospital care children reported cough, diarrhoea and feeding difficulty compared with day care children and needed more medication during the follow-up period ([table 3](#tbl3){ref-type="table"}). However, a significantly higher number of day care children reported respiratory problems such as rapid breathing and chest indrawing compared with hospital care children ([table 3](#tbl3){ref-type="table"}). Failure of both day care and hospital management were associated with the following: (1) the presence of tachycardia defined as pulse rate of more than 160 beats per minute; tachypnoea defined as respiratory rate of more than 60 breaths per minute and hypoxaemia with an oxygen saturation of \<95% as recorded by pulse oximetry,[@b17] [@b18] all on admission and (2) prolonged duration of clinic/hospital stay for more than 10 days ([table 4](#tbl4){ref-type="table"}).

###### 

Compliance rates, morbidities and medications during each of the follow-up visits of study children

                         1st follow-up visit   2nd follow-up visit   3rd follow-up visit   4th follow-up visit   5th follow-up visit   6th follow-up visit   Total
  ---------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- -----------
  Follow-up compliance   342 (95)              335 (93)              322 (89)              315 (88)              311 (86)              308 (85)              1933 (89)
  Cough                  94 (26)               108 (30)              95 (26)               106 (29)              105 (29)              97 (27)               605 (28)
  Fever                  48 (13)               60 (17)               57 (16)               72 (20)               64 (18)               64 (18)               365 (17)
  Rapid breathing        20 (6)                32 (9)                22 (6)                27 (7)                30 (8)                24 (7)                155 (7)
  Chest indrawing        17 (5)                25 (7)                20 (6)                17 (5)                14 (4)                14 (4)                107 (5)
  Feeding difficulty     9 (2)                 24 (7)                21 (6)                18 (5)                18 (5)                8 (2)                 98 (5)
  Difficult breathing    16 (4)                16 (4)                8 (2)                 11 (3)                5 (1)                 11 (3)                67 (3)
  Diarrhoea              25 (7)                41 (11)               31 (9)                34 (9)                27 (7)                35 (10)               193 (9)
  Minor illnesses        54 (15)               58 (16)               40 (11)               44 (12)               58 (16)               39 (11)               293 (14)
  Medicine taken         58 (16)               65 (18)               71 (20)               68 (19)               76 (21)               71 (20)               409 (19)

Values are n (%).

###### 

Comparison of compliance rates, morbidities and medications during the follow-up period

  Morbidity                                Day care visits (n=1080)   Hospital care visits (1080)   Total follow-up visits (2160)   OR (95% CI)           p Value
  ---------------------------------------- -------------------------- ----------------------------- ------------------------------- --------------------- ---------
  Compliance to all six follow-up visits   976 (90)                   957 (89)                      1933 (89)                       1.21 (0.91 to 1.60)   0.18
  Cough                                    281 (46)                   324 (54)                      605                             0.82 (0.68 to 0.99)   0.04
  Fever                                    177 (48)                   188 (52)                      365                             0.93 (0.74 to 1.17)   0.52
  Rapid breathing                          119 (77)                   36 (23)                       155                             3.59 (2.41 to 5.37)   \<0.001
  Chest indrawing                          74 (69)                    33 (31)                       107                             2.33 (1.51 to 3.63)   \<0.001
  Feeding difficulty                       31 (32)                    67 (68)                       98                              0.45 (0.28 to 0.70)   \<0.001
  Difficult breathing                      32 (48)                    35 (52)                       67                              0.91 (0.55 to 1.52)   0.70
  Diarrhoea                                78 (40)                    115 (60)                      193                             0.65 (0.48 to 0.89)   0.005
  Minor illnesses                          133 (45)                   160 (55)                      293                             0.81 (0.63 to 1.04)   0.08
  Medicine taken                           108 (26)                   301 (74)                      409                             0.29 (0.22 to 0.37)   \<0.001

Values are n (%).

###### 

Comparison of the study children in relation to their success and failure during the follow-up period

  Characteristic                                                  Success (n=329)   Failure (n=31)   Total (n=360)   p Value
  --------------------------------------------------------------- ----------------- ---------------- --------------- ---------
  Male, n (%)                                                     202 (61)          18 (58)          220 (61)        0.71
  Age months, mean (SD)                                           7.88 (7.01)       9.07 (11.33)     7.98 (7.46)     0.57
  Infants (2--11 months), n (%)                                   264 (80)          27 (87)          291 (81)        0.49
  Children (12--59 months), n (%)                                 65 (20)           4 (13)           69 (19)         0.49
  Breast fed, n (%)                                               303 (92)          27 (87)          330 (92)        0.25
  History of cough, n (%)                                         328 (100)         31 (100)         359 (100)       0.91
  History of fever, n (%)                                         299 (91)          29 (94)          328 (91)        0.46
  History of difficulty breathing, n (%)                          88 (27)           7 (23)           95 (26)         0.61
  History of chest wall indrawing, n (%)                          117 (36)          10 (32)          127 (35)        0.71
  Weight, kg, mean (SD)                                           6.51 (1.59)       6.10 (1.89)      6.48 (1.62)     0.17
  Height, cm, mean (SD)                                           64.69 (8.09)      64.77 (10.24)    64.69 (8.28)    0.95
  Weight-for-age Z-score, mean (SD)                               −1.37 (1.21)      −1.80 (0.85)     −1.41(1.19)     0.06
  Weight-for-height Z-score, mean (SD)                            −0.72 (2.48)      −1.07 (0.91)     −0.74 (2.39)    0.45
  Temperature of \>38°C, n (%)                                    138 (42)          14 (45)          152 (42)        0.72
  Pulse rate, beats per minute, mean (SD)                         152 (17)          164 (16)         153 (17)        0.69
  Pulse rate of \>160 beats per minute, n (%)                     82 (25)           17 (55)          99 (28)         \<0.001
  Respiratory rate, breaths per minute, mean (SD)                 62 (10)           67 (12)          62 (10)         0.007
  Respiratory rate \>60 breaths per minute, n (%)                 170 (52)          23 (74)          193 (54)        0.01
  Rales/crepitation on auscultation, n (%)                        325 (99)          31 (100)         356 (99)        1.00
  Hepatomegaly (liver palpable for \>2 cm), n (%)                 97 (29)           9 (29)           106 (29)        0.95
  Duration of stay (day care/hospital), days, mean (SD)           6.63 (2.10)       9.19 (5.21)      6.85 (2.61)     \<0.001
  Duration of stay \>10 days, n (%)                               17 (5)            7 (23)           24 (7)          \<0.001
  Duration of antibiotic (Ceftriaxone) therapy, days, mean (SD)   6.97 (1.59)       7.84 (2.31)      7.04 (1.67)     0.006
  Hypoxaemia at admission (oxygen saturation \<95%), n (%)        164 (50)          25 (81)          189 (53)        0.001
  Oxygen saturation at admission, mean (SD)                       94.92 (3.48)      91.32 (5.54)     94 (4)          \<0.001

Successful follow-up visits for 3 months were possible in 146/180 (OR 81.1 (95% CI 74.8 to 86.2)) children who received day care, while it was possible in 162/180 (OR 90 (95% CI 84.7 to 93.6)) children who received hospital care ([table 5](#tbl5){ref-type="table"}). However, the remaining children failed to day care/hospital care management for re-hospitalisation, or development of hypoxaemia or death during the follow-up period ([table 5](#tbl5){ref-type="table"}). A significantly higher number of day care children (n=22 (OR 12.2 (95% CI 8.2 to 17.8))) required re-hospitalisation compared with hospital care children (n=11 (OR 6.1 (95% CI 3.4 to 10.6))) (OR 2.14, p=0.04) ([table 5](#tbl5){ref-type="table"}), as more day care children had hypoxaemia (n=12 (OR 6.7 (95% CI 3.9 to 11.3))) compared with the hospital care group (n=4 (OR 2.2 (95% CI 0.9 to 5.6))) (OR 3.14, p=0.04) ([table 5](#tbl5){ref-type="table"}). Similarly, a significantly higher number of children who presented with hypoxaemia during the acute phase of illness (n=25 (OR 13.2 (95% CI 9.1 to 18.8))) required re-hospitalisation during the follow-up period (OR 3.11, p=0.004) (data not shown here)[@b15] compared with children who did not present with hypoxaemia during that phase of illness (n=8 (OR 4.7 (95% CI 2.4 to 9))). There were no deaths during the acute-phase care of children in either the day care or hospital care setting. During the follow-up period, no child in the day care group died but two (OR 1.1 (95% CI 0.3 to 4)) children in the hospital care group died and one (OR 0.6 (95% CI 0.1 to 3.1)) child died after the 3-month follow-up period.

###### 

Outcome for study children during the follow-up period

  Characteristic                                        Day care (n=180), n (OR (95% CI))   Hospital care (n=180), n (OR (95% CI))   Total (n=360), n (OR (95% CI))   OR (95% CI)            p Value
  ----------------------------------------------------- ----------------------------------- ---------------------------------------- -------------------------------- ---------------------- ---------
  Successful follow-up visits                           146 (81.1% (74.8% to 86.2%))        162 (90% (84.7% to 93.6%))               308 (85.6% (81.5% to 88.8%))     0.48 (0.25 to 0.92)    0.01
  Failure                                               34 (18.9% (13.8% to 25.2%))         18 (10% (6.4% to 15.3%))                 52 (14.4% (11.2% to 18.5%))      2.10 (1.09 to 4.05)    0.01
  Re-hospitalisation during the follow-up period        22 (12.2% (8.2% to 17.8%))          11 (6.1% (3.4% to 10.6%))                33 (9.2% (6.6% to 12.6%))        2.14 (0.95 to 4.88)    0.04
  Development of hypoxaemia (oxygen saturation \<95%)   12 (6.7% (3.9% to 11.3%))           4 (2.2% (0.9% to 5.6%))                  16 (4.4% (2.8% to 7.1%))         3.14 (0.92 to 11.80)   0.04
  Death[\*](#table-fn1){ref-type="table-fn"}            0 (0% (0% to 2.1%))                 3\* (1.7% (0.6% to 4.8%))                3\* (0.8% (0.3% to 2.4%))        0                      0.12

Only one child died after 3-month follow-up period.

Discussion
==========

In our study, we noted the great importance of follow-up after discharge from the clinic/hospital as some children relapsed or developed morbidities, and others needed unscheduled extra-clinic/hospital visits or re-hospitalisation, and a small number died during this period. Results from our study suggest the need to establish routine follow-up of children following successful management of severe pneumonia at healthcare facilities in order to detect medical problems early and to enable appropriate management and to prevent death. Such follow-up should be ideally done at the same healthcare facilities where the children had received their initial treatment, but a community follow-up system may be possible if trained and motivated community health workers and adequate resources are available.[@b13] [@b19]

In our study, the follow-up compliance reduced over time. However, it was still impressive (85%) even at the end of 3 months ([table 2](#tbl2){ref-type="table"})---a finding of considerable importance. Moreover, this impressive rate of follow-up was spontaneous---around 95% children were brought by their parents and the remaining 5% came after healthcare workers made home visits encouraging them to come. In general, incentives were not given but the study did support the conveyance costs of very poor families (4%) with a monthly income of about US\$30 only. The finding that significantly more day care children suffered from rapid breathing and chest indrawing might be explained by the relatively more severe illness defined by hypoxaemia among them compared with the hospital care group. But, the hospital care group had significantly more feeding difficulty and diarrhoeal illness leading to consumption of more medications ([table 3](#tbl3){ref-type="table"}). The predictors for failure were the presence of tachycardia, tachypnoea and hypoxaemia on admission and prolonged duration of stay. Therefore, children presenting with tachycardia, tachypnoea and hypoxaemia on admission should be carefully monitored and aggressively treated, as they are unlikely to improve with routine therapy leading to prolonged stay. Similarly, the presence of tachycardia, tachypnoea and hypoxaemia on admission are also indicators for severe illness leading to failure of routine treatment.

Previous studies in Pakistan of community management of pneumonia by lady health worker with oral antibiotics[@b10] and ambulatory home treatment with high-dose oral amoxicillin,[@b11] without any necessity for referral to hospitals and without any injectable antibiotics, as well as without needing any oxygen therapy for hypoxaemia, have been reported. Our patient population probably had more severe disease judged by hypoxaemia, as 53% of our children were hypoxaemic on admission.[@b15]

There were some important limitations to our study. We could not assess the sustainability of a programme of 3-month follow-up visits at respective healthcare facilities where children had received their initial treatment. The feasibility as well as the sustainability of community follow-up should be assessed in future studies.

Conclusions
-----------

Successful follow-up visits for 3 months were possible in 81% of the day care children, while it was possible in 90% of the hospital care children. However, the remaining children failed to day care/hospital care management for re-hospitalisation, or development of hypoxaemia or death during the follow-up period. Children receiving apparently effective treatment of severe pneumonia experienced considerable morbidity due to cough, fever, rapid breathing and diarrhoea following discharge. The predictors for failure include the presence of tachycardia, tachypnoea and hypoxaemia on admission and prolonged duration of stay. These findings indicate the importance of follow-up of children with severe pneumonia irrespective of their primary site of management (day care clinic or hospital) for early detection and efficient management of subsequent medical problems and to reduce the risk of death. Establishment of an effective community follow-up of non-compliant children, whenever possible, would be ideal to address the problem of 'non-compliance with follow-up'.

Trial registration
==================

The original randomised controlled trial comparing the day care management with hospital management[@b15] has been registered at <http://www.clinicaltrials.gov> (identifier NCT00455468).
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